-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Instruction of Hexahydro-1-[5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2-pyrimidinyl]-1H-azepine: A Comprehensive Guide for the Chemical Industry
Hexahydro-1-[5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2-pyrimidinyl]-1H-azepine, also known as BNFL-301, is a novel and promising compound that has recently gained attention in the chemical industry.
It is an azepine derivative that has been synthesized through a series of chemical reactions, and its unique structure and properties make it a highly sought-after material for various applications.
In this article, we will provide a comprehensive guide on the instruction of Hexahydro-1-[5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2-pyrimidinyl]-1H-azepine, including its synthesis, properties, and applications.
This guide is intended for those who are interested in working with this compound, including chemists, researchers, and chemical engineers.
Synthesis of Hexahydro-1-[5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2-pyrimidinyl]-1H-azepine
Hexahydro-1-[5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2-pyrimidinyl]-1H-azepine can be synthesized through a multi-step reaction process.
The synthesis of this compound typically involves the following steps:
Step 1: Preparation of 2,4-dibromo-6-chloropyrimidine
In this step, 2,6-dibromopyrimidine is treated with chlorine gas and sodium hydroxide to form 2,4-dibromo-6-chloropyrimidine.
Step 2: Preparation of 2-chloro-5-methyl-1,3-oxazepanecarbonitrile
In this step, 2,4-dibromo-6-chloropyrimidine is treated with sodium cyanide and dimethylformamide to form 2-chloro-5-methyl-1,3-oxazepanecarbonitrile.
Step 3: Preparation of N-[(2S)-2-(dibromoacetyl)amino-5,6-dihydroimidazo[1,2-d][1,4]benzoxazepine-3-carboxamide
In this step, 2-chloro-5-methyl-1,3-oxazepanecarbonitrile is treated with N-hydroxysuccinimide and (S)-2-(dibromoacetyl)amino-5,6-dihydroimidazo[1,2-d][1,4]benzoxazepine to form N-[(2S)-2-(dibromoacetyl)amino-5,6-dihydroimidazo[1,2-d][1,4]benzoxazepine-3-carboxamide.
Step 4: Preparation of 1-(5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2-pyrimidinyl